我要投票 海力生在胶原蛋白行业中的票数:786
· 外 推 电 报 ·
2025-08-20 21:42:55 星期三

【海力生是哪个国家的品牌?】

海力生是什么牌子?「海力生」是 浙江海力生生物科技股份有限公司 旗下著名品牌。该品牌发源于浙江,由创始人王加斌在2004-10-11期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力海力生品牌出海!将品牌入驻外推网,定制海力生品牌推广信息,可以显著提高海力生产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

浙江海力生生物科技有限公司为海力生集团(1954年成立,“海力生”商标为浙江省著名商标)旗下骨干企业之一。成立于2004年10月,总投资5000万元人民币。是一个拥有雄厚技术力量,先进生产设备,集研发、生产、销售为一体的高新技术企业。公司凭借多年出口实力一举通过ISO9001、ISO22000质量体系认证和清真、GMP认证、QS认证和国际食品安全HACCP验证。生产车间占地面积2.5公顷(海力生集团占地20公顷),设有完整的新产品研发机构和检测中心,保健食品GMP生产车间1500平方米,出口食品HACCP生产车间4600平方米。其中深海鱼胶原蛋白肽项目是国家发改委国债支持项目,胶原蛋白肽车间是目前国内规模最大、设备最先进、技术力量最强、产品最完善的生产车间。

海力生生物科技凭借雄厚的研发能力和多领域的生产能力被中国医师协会营养医师专业委员会指定为“中国临床医用食品研发、生产基地”,承担起振兴民族医用食品事业的重任。在2009年海力生生物科技承办的“中国医师协会工作会和中国医师协会营养医师专业委员会2009年年会”上,发起并筹建了临床营养发展基金,大力资助临床营养领域学术交流和人才培养;为推动我国临床营养学科的标准化建设作出了积极贡献。

海力生生物科技以前瞻的眼光,在我国医药体制改革方针指引下,2009年建成并开通运用中国第一家“携医网络医院”,以先进的科技手段打破地域界限将患者和医生、医院和医院拉近到一个全新的平台上,真正实现了医疗资源的合理配置。

目前海力生生物科技形成了医用食品和保健食品两大产品体系,医用食品主要有:FD匀浆膳、大元素系列产品、大元素组件产品等30余个品种;保健食品主要有:灵芝、姬松茸提取物(软、硬胶囊)、脑元神胶囊和深海鱼胶原蛋白肽(原料、胶囊、粉剂、颗粒剂)。其中灵芝、姬松茸提取物采用日本最新工艺,β-D葡聚糖含量分别达到45%与20%。产品多次荣获国家、部、省、厅的优质产品、科技进步奖、浙江省名牌和高质量医用食品等称号。2009年12月被浙江省科技厅授予“浙江省农业科技企业”光荣称号。

海力生生物科技载“营养中国”重任而行,汇聚了“阳光、关爱、健康”的企业精神;集海力生55年文化底蕴,以提供“专业、安全、安心”的产品和售后服务为核心,着眼中国,放眼世界,努力开拓健康产业新纪元。

英文翻译:Zhejiang hynixon Biotechnology Co., Ltd. is one of the backbone enterprises of hynixon group (established in 1954, "hynixon" trademark is a famous trademark of Zhejiang Province). It was founded in October 2004 with a total investment of 50 million yuan. Is a strong technical force, advanced production equipment, research and development, production, sales as one of the high-tech enterprises. With years of export strength, the company has passed ISO9001, ISO22000 quality system certification, halal, GMP certification, QS certification and international food safety HACCP certification. The production workshop covers an area of 2.5 hectares (hynixon group covers an area of 20 hectares), with a complete new product R & D organization and testing center, 1500 square meters of GMP production workshop for health food and 4600 square meters of HACCP production workshop for export food. Among them, the deep sea fish collagen peptide project is a national debt support project of the national development and Reform Commission. The collagen peptide workshop is currently the largest production workshop in China, with the most advanced equipment, the strongest technical force and the most perfect products. With strong R & D capacity and multi field production capacity, hynixon biotechnology has been designated as the "research and development and production base of Chinese clinical medical food" by the nutritionist Professional Committee of Chinese Medical Doctor Association, and undertakes the important task of revitalizing the national medical food industry. In 2009, at the "working meeting of Chinese Medical Association and 2009 annual meeting of nutrition doctors professional committee of Chinese Medical Association" organized by hynixon biotechnology, it initiated and prepared the clinical nutrition development fund, which vigorously supported academic exchanges and personnel training in the field of clinical nutrition, and made positive contributions to promoting the standardization construction of clinical nutrition discipline in China. With a forward-looking vision and under the guidance of China's pharmaceutical system reform policy, hynixon biotechnology established and opened the first "medical network hospital" in China in 2009, breaking the regional boundaries with advanced scientific and technological means, bringing patients, doctors, hospitals and hospitals closer to a new platform, and truly realizing the rational allocation of medical resources. At present, hynixon biotechnology has formed two major product systems: medical food and health food. Medical food mainly includes more than 30 varieties, such as FD homogenate diet, large element series products and large element component products. Health food mainly includes: Ganoderma lucidum, Agaricus blazei extract (soft and hard rubber capsule), naoyuanshen capsule and deep sea fish collagen peptide (raw material, capsule, powder and granule). The content of β - D-glucan in Ganoderma lucidum and Agaricus blazei was 45% and 20% respectively. The products have won the titles of high-quality products, science and technology progress award, famous brand and high-quality medical food of Zhejiang Province. In December 2009, it was awarded the honorable title of "Zhejiang agricultural science and technology enterprise" by Zhejiang science and technology department. With the mission of "nourishing China", hynixon biotechnology has gathered the enterprise spirit of "sunshine, care and health"; with the 55 years of cultural heritage of hynixon, with the core of providing "professional, safe and reassuring" products and after-sales services, it focuses on China, looks at the world and strives to open a new era of health industry.

本文链接: https://www.waitui.com/brand/caefe11f6.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

江波龙:员工持股平台拟合计减持公司不超1.31%股份

36氪获悉,江波龙公告,龙熹一号、龙熹二号、龙熹三号、龙舰管理、龙熹五号(统称“员工持股平台”)合计持有公司16.53%股份,计划在2025年9月11日至12月10日期间通过集中竞价交易方式和大宗交易方式合计减持公司股份不超过548万股(不超过公司总股本的1.31%)。

2小时前

云南锗业:公司及鑫耀公司目前并无6英寸磷化铟晶片规模化量产的具体计划

36氪获悉,云南锗业发布股票交易异常波动公告,公司了解到,近期有国内研发机构发布了其在6英寸磷化铟外延生长工艺领域实现了技术突破相关事宜。就控股子公司鑫耀公司而言,在2-4英寸规格的磷化铟晶片量产后,为应对未来的市场需求,对更大尺寸的产品开展了研究开发,但从研发到规模化生产尚存在较大不确定性。公司及鑫耀公司目前并无6英寸磷化铟晶片规模化量产的具体计划,下一步在市场与需求风险、技术风险等可控的前提下,公司方会考虑相关计划,如有相关计划,公司会按规定进行公开披露。

2小时前

胜宏科技:向香港联交所递交H股发行并上市申请并刊发申请资料

36氪获悉,胜宏科技公告,公司已于2025年8月20日向香港联交所递交了发行境外上市股份(H股)并在香港联交所主板挂牌上市的申请,并于同日在香港联交所网站刊登了本次发行的申请资料。该申请资料为草拟版本,其所载资料可能会适时作出更新及修订。公司本次发行尚需取得相关政府机关、监管机构、证券交易所的批准、核准或备案。

2小时前

永辉超市:上半年净亏损2.41亿元

36氪获悉,永辉超市公告,公司上半年实现营业总收入299.48亿元,同比下降20.73%;净亏损2.41亿元,上年同期盈利2.75亿元。

2小时前

摩根大通与三菱日联接近达成220亿美元的得州数据中心融资协议

英国《金融时报》周三报道,摩根大通和日本三菱日联金融集团正就为得克萨斯州一个数据中心承销220亿美元贷款展开谈判。报道称,该规划中的园区将由Vantage Data Centers所有,这是一家由银湖资本和资产管理公司DigitalBridge 控股的数字基础设施企业。报道还指出,银湖资本和DigitalBridge将合计承诺30亿美元股权,助力该数据中心园区的建设。(新浪财经)

2小时前

本页详细列出关于海力生的品牌信息,含品牌所属公司介绍,海力生所处行业的品牌地位及优势。
咨询